Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Cell Reports
|
September 15, 2023
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, et al.
The Journal of Clinical Investigation
|
July 3, 2025
Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma
Jithma P Abeykoon, Shuhei Asada, Guangli Zhu, et al.
Nature Communications
|
January 13, 2022
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Yosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing Sarcoma
Shuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
Communications Biology
|
December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
Emi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Blood
|
June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1
Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature Communications
|
March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
Takeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Nature Cardiovascular Research
|
December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity
Naru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Journal of Biochemistry
|
November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)
Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
EMBO Molecular Medicine
|
December 1, 2022
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia
Xiaoxiao Liu, Naru Sato, Tomohiro Yabushita, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Cell Reports
|
September 15, 2023
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, et al.
The Journal of Clinical Investigation
|
July 3, 2025
Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma
Jithma P Abeykoon, Shuhei Asada, Guangli Zhu, et al.
Nature Communications
|
January 13, 2022
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Yosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing Sarcoma
Shuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
Communications Biology
|
December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
Emi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Blood
|
June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1
Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature Communications
|
March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
Takeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Nature Cardiovascular Research
|
December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity
Naru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Journal of Biochemistry
|
November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)
Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
EMBO Molecular Medicine
|
December 1, 2022
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia
Xiaoxiao Liu, Naru Sato, Tomohiro Yabushita, et al.
Page
of 4